Randomized, placebo-controlled trial of an AMPAkine [farampator] in major depressive disorder.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 26 Jun 2015
At a glance
- Drugs Farampator (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 24 Feb 2012 Primary endpoint added as reported by ClinicalTrials.gov.
- 06 Sep 2006 New trial record.